Effects of Omega-3 and Whey Protein Supplementation on Lean Mass in Older Adults
NCT ID: NCT05862779
Last Updated: 2024-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2024-07-30
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whey Protein Supplementation and Resistance Training in Older Women With Sarcopenic Obesity.
NCT03752359
Effect of Protein Consumption and Resistance Training on Body Composition, Muscular Strength and Functional Capacity in the Elderly
NCT03862937
Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women
NCT03247192
Protein Supplementation: Body Composition, Muscle Strength and Postural Balance
NCT03792646
Protein Timing, Lean Mass, Strength and Functional Capacity Gains in Postmenopausal Women
NCT03372876
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo Group
Group supplemented with maltodextrin (40g/day) and corn oil (4g/day). All groups will undergo a training program with strength exercises for 12 weeks
Placebo Group
The placebo group will receive 4 g per day of corn oil and 40 g per day of maltodextrin.
Whey Protein + Placebo
Group supplemented with isolated whey protein (40g/day) and corn oil (4g/day). All groups will undergo a training program with strength exercises for 12 weeks.
Whey Protein + Placebo
The whey protein + placebo group will receive 40g per day of whey and 4g per day of corn oil.
Omega 3 + Placebo
Group supplemented with omega-3 (4g/day) and maltodextrin (40g/day). All groups will undergo a training program with strength exercises for 12 weeks.
Omega 3 + Placebo
The omega 3 + placebo group will receive 4 g per day of fish oil and 40 g per day of maltodextrin.
Omega 3 + Whey Protein
Group supplemented with omega-3 (4g/day) and whey protein (40g/day). All groups will undergo a training program with strength exercises for 12 weeks.
Omega 3 + Whey Protein
The omega 3 + whey group will receive 4g per day of fish oil and 40g per day of protein.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo Group
The placebo group will receive 4 g per day of corn oil and 40 g per day of maltodextrin.
Whey Protein + Placebo
The whey protein + placebo group will receive 40g per day of whey and 4g per day of corn oil.
Omega 3 + Placebo
The omega 3 + placebo group will receive 4 g per day of fish oil and 40 g per day of maltodextrin.
Omega 3 + Whey Protein
The omega 3 + whey group will receive 4g per day of fish oil and 40g per day of protein.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be able to practice strength exercises;
* To be able to carry out supplementation;
* Do not present physical, orthopedic or cardiovascular complications that prevent the performance of physical exercises;
* No history of stroke or acute myocardial infarction;
* Not being a smoker and/or alcoholic;
* Do not perform hormone replacement therapy;
* Do not use anti-inflammatory drugs;
* To have normal kidney function;
* To submit a medical certificate of health that proves that the individual is able to perform exercises.
Exclusion Criteria
* Individuals with diseases previously diagnosed and undergoing treatment, such as type II diabetes mellitus, cancer, rheumatoid arthritis, high blood pressure, dyslipidemia, cardiovascular, and kidney and/or liver diseases.
60 Years
85 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Uberlandia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erick Prado de Oliveira
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Uberlandia
Uberlândia, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5.728.049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.